• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Former Trump Administration VA Secretary Peter O'Rourke Sr. Joins Quantum Cyber's Board of Directors

    5/14/26 8:01:00 AM ET
    $NVAC
    $PFSA
    $QUCY
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $NVAC alert in real time by email

    WEST PALM BEACH, Fla, May 14, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a company assembling an AI-powered System-of-Systems autonomous defense platform spanning drone warfare, counter-UAS, demining, and command-and-control applications, today announced the appointment of Peter M. O'Rourke Sr. as an independent member of its Board of Directors, effective immediately.

    Mr. O'Rourke served as Acting Secretary of the U.S. Department of Veterans Affairs (VA) under the Trump administration in 2018, where he led over 380,000 employees and helped oversee one of the largest federal healthcare and benefits systems in the country, with an annual budget exceeding $180 billion at the time. Before his role as Acting Secretary, he served as Chief of Staff and Senior Advisor to the Secretary, where he championed the bipartisan VA Mission Act and guided strategic alignment with White House defense and veterans initiatives, and played a key leadership role in standing up the VA Office of Accountability and Whistleblower Protection to strengthen oversight, transparency, and accountability across the Department. Mr. O'Rourke is a U.S. military veteran, having served as a Commissioned Officer in the U.S. Air Force from 1998 to 2006 and as an Enlisted Airman in the U.S. Navy aboard the USS Abraham Lincoln from 1990 to 1994. He holds a Master of Science degree from the Air Force Institute of Technology and a Department of Defense Top Secret SCI Security Clearance (inactive).

    Mr. O'Rourke brings significant Nasdaq board experience to Quantum Cyber, having served as Chairman of Northview Acquisition Corporation (NASDAQ:NVAC), and Lead Independent Director of ProFusa (NASDAQ:PFSA). He is the Founder and Managing Partner of TCI Partners LLC, a consulting firm focused on defense, healthcare, and government engagement, and serves as President and Founder of the National Association for Veterans Rights.

    "Peter's appointment is a defining moment for Quantum Cyber," said David Lazar, Chief Executive Officer. "We are assembling the autonomous defense platform of the future, and having a former Acting Secretary of the VA, a decorated military veteran, and an experienced Nasdaq board chairman at our table signals to the market, to government partners, and to investors exactly where this company is going. Peter's network, his DoD experience, and his understanding of the intersection between government procurement and capital markets are precisely what we need at this stage of our platform build."

    "Autonomous defense systems and drone technology are rapidly becoming foundational to the future of national security and global defense infrastructure," said Peter O'Rourke Sr. "The Trump administration has made clear that rebuilding American defense capability through advanced autonomous systems and next-generation military technology is a national priority, and the funding momentum reflects that commitment. Quantum Cyber is uniquely positioned at the intersection of cybersecurity, autonomy, and defense innovation, with a System-of-Systems platform that aligns directly with the evolving needs of both government and industry. I'm excited to support the Company's strategic growth and help advance its long-term vision."

    The appointment of Mr. O'Rourke follows Quantum Cyber's recently announced IP License Agreement and Commercial Supply Agreement with BP United Inc. for autonomous drone technology, and advances the Company's strategy of assembling a diversified System-of-Systems autonomous defense platform combining Israeli battlefield-proven technology with U.S. capital markets access and government procurement relationships.

    About Quantum Cyber N.V.

    Quantum Cyber N.V. (NASDAQ:QUCY) is assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform that integrates drone warfare, counter-UAS, autonomous demining, command-and-control, and quantum-accelerated defense applications under a single Nasdaq-listed holding company. The Company acquires, licenses, and develops combat-proven autonomous technologies, deploying them as a coordinated, multi-domain portfolio across air, land, and sea. Quantum Cyber draws on Israeli battlefield-proven systems and U.S. capital markets access to build the autonomous defense platform of the next generation of unmanned warfare. For more information, visit https://quantum-cyber.ai/

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are statements that are not historical facts, including statements regarding the Company's anticipated technology acquisitions, commercial agreements, board composition, revenue generation, and overall business strategy. Such statements involve known and unknown risks and uncertainties that could cause actual results to differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the Company's ability to execute on its business plan, the status and timing of technology integrations, market and regulatory conditions in the defense technology sector, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

    Investor Relations Contact

    Arx Investor Relations

    North American Equities Desk

    Email: qucy@arxhq.com

    Web: www.quantum-cyber.ai



    Primary Logo

    Get the next $NVAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NVAC
    $PFSA
    $QUCY

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $NVAC
    $PFSA
    $QUCY
    SEC Filings

    View All

    Mainz Biomed N.V. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Quantum Cyber N.V. (0001874252) (Filer)

    6/3/26 8:44:08 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Mainz Biomed N.V.

    DEF 14A - Quantum Cyber N.V. (0001874252) (Filer)

    6/1/26 5:19:22 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mainz Biomed N.V. filed SEC Form 8-K: Other Events

    8-K - Quantum Cyber N.V. (0001874252) (Filer)

    5/28/26 4:05:36 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NVAC
    $PFSA
    $QUCY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Drones-as-a-Service Market Surges as AI, Automation, and Industrial Demand Drive Billion-Dollar Growth

    Market forecasts point to multi-billion-dollar expansion as businesses increasingly adopt outsourced drone operations to reduce costs and improve efficiencyNEW YORK, June 3, 2026 /CNW/ -- Market News Updates News Commentary - The concept of Drones as a Service (DaaS) is rapidly gaining momentum within the broader AI, automation, and industrial technology sectors. This trend is driven by businesses seeking cost-effective solutions for drone operations without the need to internally manage fleets. Instead of investing heavily in various aspects like hardware, software, pilots, compliance, and maintenance, companies are turning to subscription and on-demand service models to outsource their dro

    6/3/26 9:20:00 AM ET
    $ONDS
    $QUCY
    $UAVS
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Publishes Inaugural Corporate Investor Presentation Showcasing System-of-Systems Autonomous Defense Platform, Eight Filed Patent Positions, LOIs With General Cherry and SOCOM, and $15 Million Debt-Free Balance Sheet

    WEST PALM BEACH, Florida, June 03, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today published its inaugural Corporate Investor Presentation. The full presentation is available at https://quantum-cyber.ai/investors/presentations. The 19-slide deck consolidates the Company's previously announced milestones, technology portfolio, and strategic positioning into a single investor-facing document. Key sections include: Battle-Validated Autonomy and the QC-Core Platform. Ukra

    6/3/26 8:13:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Assumes Direct Manufacturing of Autonomous Drone; Expands BP United Agreement

    WEST PALM BEACH, Florida, June 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced an expansion of its existing relationship with BP United Inc. ("BP United"), the developer of autonomous unmanned vehicle systems that form the foundation of the Company's autonomous drone platform. Quantum Cyber Assumes Direct Manufacturing ControlThe Company and BP United have executed a First Amendment to the Intellectual Property License Agreement dated May 12, 2026 (the "A

    6/2/26 7:30:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NVAC
    $PFSA
    $QUCY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ben-Tzvi Avraham was granted 137,141 units of Ordinary Shares, increasing direct ownership by 6,857% to 139,141 units (SEC Form 4)

    4 - Quantum Cyber N.V. (0001874252) (Issuer)

    5/26/26 6:12:13 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider O'Rourke Peter claimed no ownership of stock in the company (SEC Form 3)

    3 - Quantum Cyber N.V. (0001874252) (Issuer)

    5/21/26 7:07:23 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Natan David was granted 137,141 units of Ordinary Shares (SEC Form 4)

    4 - Quantum Cyber N.V. (0001874252) (Issuer)

    5/21/26 7:07:00 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NVAC
    $PFSA
    $QUCY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NorthView Acquisition Corporation

    SC 13G - NorthView Acquisition Corp (0001859807) (Subject)

    3/27/24 6:05:55 AM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by NorthView Acquisition Corporation (Amendment)

    SC 13G/A - NorthView Acquisition Corp (0001859807) (Subject)

    2/22/24 9:05:41 AM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by NorthView Acquisition Corporation (Amendment)

    SC 13G/A - NorthView Acquisition Corp (0001859807) (Subject)

    2/14/24 4:53:53 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    $NVAC
    $PFSA
    $QUCY
    Leadership Updates

    Live Leadership Updates

    View All

    Former Trump Administration VA Secretary Peter O'Rourke Sr. Joins Quantum Cyber's Board of Directors

    WEST PALM BEACH, Fla, May 14, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a company assembling an AI-powered System-of-Systems autonomous defense platform spanning drone warfare, counter-UAS, demining, and command-and-control applications, today announced the appointment of Peter M. O'Rourke Sr. as an independent member of its Board of Directors, effective immediately. Mr. O'Rourke served as Acting Secretary of the U.S. Department of Veterans Affairs (VA) under the Trump administration in 2018, where he led over 380,000 employees and helped oversee one of the largest federal healthcare and benefits systems in the country, with an annual bu

    5/14/26 8:01:00 AM ET
    $NVAC
    $PFSA
    $QUCY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

    Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black & Decker, and DuPont Berkeley, Calif, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, announces two major leadership additions as of the close of the business combination with NorthView Acquisition Corp (NVAC).  Peter O'Rourke, former Acting U.S. Secretary of Veterans Affair

    8/19/25 8:15:00 AM ET
    $PFSA
    Medical/Dental Instruments
    Health Care

    $NVAC
    $PFSA
    $QUCY
    Financials

    Live finance-specific insights

    View All

    Quantum Cyber Publishes Inaugural Corporate Investor Presentation Showcasing System-of-Systems Autonomous Defense Platform, Eight Filed Patent Positions, LOIs With General Cherry and SOCOM, and $15 Million Debt-Free Balance Sheet

    WEST PALM BEACH, Florida, June 03, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today published its inaugural Corporate Investor Presentation. The full presentation is available at https://quantum-cyber.ai/investors/presentations. The 19-slide deck consolidates the Company's previously announced milestones, technology portfolio, and strategic positioning into a single investor-facing document. Key sections include: Battle-Validated Autonomy and the QC-Core Platform. Ukra

    6/3/26 8:13:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Assumes Direct Manufacturing of Autonomous Drone; Expands BP United Agreement

    WEST PALM BEACH, Florida, June 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced an expansion of its existing relationship with BP United Inc. ("BP United"), the developer of autonomous unmanned vehicle systems that form the foundation of the Company's autonomous drone platform. Quantum Cyber Assumes Direct Manufacturing ControlThe Company and BP United have executed a First Amendment to the Intellectual Property License Agreement dated May 12, 2026 (the "A

    6/2/26 7:30:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Announces Plans to Establish U.S.-Based Defense-Technology Manufacturing Complex to Support Drone and Autonomous Systems Delivery

    WEST PALM BEACH, Florida, May 28, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company, today announced a strategic initiative to establish a U.S.-based defense-technology manufacturing complex intended to support the production and delivery of autonomous drone and defense systems to end customers across federal government, Homeland Security, local government, and commercial sectors. Illustrations shown are conceptual and provided for marketing and visualization purposes only. Certain depicted systems, capabilities, payloads, specifications, and operational use cases may be under development, subject to change, or not currently

    5/28/26 7:00:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care